SUBSCRIBE
SUBSCRIBE
News   Drug Development

ITI Announces New Progress Milestones in Its Development Program for Acute Repetitive Seizure in Epilepsy

December 8, 2008 | 
1 min read
SADDLE BROOK, N.J.--(BUSINESS WIRE)--ITI, a privately held specialty pharmaceutical company, today announced that the company has achieved several important developments in its epilepsy product program, including
Clinical research Phase 2
MORE ON THIS TOPIC
Illustration of man walking in the beach between two blue seas, surreal abstract path concept
Rare disease
FDA’s Bespoke Pathway To Focus on Gene Editing and RNA-Based Treatments for Rare Diseases
February 23, 2026
 · 
3 min read
 · 
Nick Paul Taylor
Concept of saving money with a pink colored piggy bank held in a hand in front of a blackboard with hand drawn coins
Weight loss
Novo’s CagriSema Falls to Lilly’s Zepbound in Daring Head-to-Head Test
February 23, 2026
 · 
4 min read
 · 
Annalee Armstrong
Insights
Historic ALS Investment Signals New Treatment Momentum
February 23, 2026
 · 
3 min read
 · 
Jennifer Smith-Parker
Human hands holding colorful pieces of puzzle. Vector hand drawn sketch illustration. Business team solving problem, joining and connecting jigsaw. Teamwork, partnership, business solution concept
MASH
Beyond Rezdiffra: The 4 Most Promising MASH Pipelines in Play
February 23, 2026
 · 
6 min read
 · 
Ben Hargreaves